Portal de Periódicos da CAPES

Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation? – An American view

2002; Wiley; Volume: 118; Issue: 2 Linguagem: Inglês

10.1046/j.1365-2141.2002.03701.x

1365-2141

Allen Chen, Todd A. Alonzo, William G. Woods, R.J. Arceci,

Retinoids in leukemia and cellular processes

British Journal of HaematologyVolume 118, Issue 2 p. 378-384 Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation? – An American view Allen R. Chen, Allen R. Chen Departments of Oncology and Pediatrics, Division of Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD,Search for more papers by this authorTodd A. Alonzo, Todd A. Alonzo Children's Oncology Group Operations Center, Arcadia, CA, andSearch for more papers by this authorWilliam G. Woods, William G. Woods Cancer Center and Blood Disorder Service, Children's Healthcare of Atlanta at Egleston, Atlanta, GA, USASearch for more papers by this authorRobert J. Arceci, Robert J. Arceci Departments of Oncology and Pediatrics, Division of Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD,Search for more papers by this author Allen R. Chen, Allen R. Chen Departments of Oncology and Pediatrics, Division of Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD,Search for more papers by this authorTodd A. Alonzo, Todd A. Alonzo Children's Oncology Group Operations Center, Arcadia, CA, andSearch for more papers by this authorWilliam G. Woods, William G. Woods Cancer Center and Blood Disorder Service, Children's Healthcare of Atlanta at Egleston, Atlanta, GA, USASearch for more papers by this authorRobert J. Arceci, Robert J. Arceci Departments of Oncology and Pediatrics, Division of Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, MD,Search for more papers by this author First published: 25 July 2002 https://doi.org/10.1046/j.1365-2141.2002.03701.xCitations: 44 Allen R. Chen, M.D., Ph.D, and Robert J. Arceci, M.D., Ph.D., Departments of Oncology and Pediatrics, Division of Pediatric Oncology, CMSC 800, Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Baltimore, MD 21287, USA. E-mail: [email protected]; [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Amadori, S., Ceci, A., Comelli, A., Madon, E., Masera, G., Nespoli, L., Paolucci, G., Zanesco, L., Vegna, M.L., Moleti, M.L., Testi, A.M. & Mandelli, F. (1990) Therapy of childhood acute myelogenous leukemia: an update of the AIEOP/LAM 8204 study. Italian Pediatric Hematology–Oncology Association. Haematology and Blood Transfusion, 33, 222–225. 10.1007/978-3-642-74643-7_40 CASPubMedGoogle Scholar Amadori, S., Testi, A.M., Arico, M., Comelli, A., Giuliano, M., Madon, E., Masera, G., Rondelli, R., Zanesco, L. & Mandelli, F. (1993) Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group. Journal of Clinical Oncology, 11, 1046–1054. 10.1200/JCO.1993.11.6.1046 PubMedWeb of Science®Google Scholar Appelbaum, F.R., Dahlberg, S., Thomas, E.D., Buckner, C.D., Cheever, M.A., Clift, R.A., Crowley, J., Deeg, H.J., Fefer, A., Greenberg, P.D., Kadin, M., Smith, W., Stewart, P., Sullivan, K., Storb, R. & Weiden, P. (1984) Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. Annals of Internal Medicine, 101, 581–588. 10.7326/0003-4819-101-5-581 CASPubMedWeb of Science®Google Scholar Appelbaum, F.R., Fisher, L.D. & Thomas, E.D. (1988)Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-up. Blood, 72, 179–184. PubMedWeb of Science®Google Scholar Bearman, S.I., Mori, M., Beatty, P.G., Meyer, W.G., Buckner, C.D., Petersen, F.B., Sanders, J.E., Anasetti, C., Martin, P., Appelbaum, F.R. & Hansen, J.A. (1994) Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors. Bone Marrow Transplantation, 13, 31–35. PubMedWeb of Science®Google Scholar Byrd, J.C., Dodge, R.K., Carroll, A., Baer, M.R., Edwards, C., Stamberg, J., Qumsiyeh, M., Moore, J.O., Mayer, R.J., Davey, F., Schiffer, C.A. & Bloomfield, C.D. (1999) Patients with t (8;21) (q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. Journal of Clinical Oncology, 17, 3767–3775. 10.1200/JCO.1999.17.12.3767 CASPubMedWeb of Science®Google Scholar Chiang, K.Y., Weisdorf, D.J., Davies, S.M., Enright, H., Kersey, J.H., McGlave, P.B., Miller, W., Ramsay, N.K., Steinbuch, M., Wagner, J.E. & Blazar, B.R. (1996) Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse. Bone Marrow Transplantation, 17, 39–42. PubMedWeb of Science®Google Scholar Clift, R.A., Buckner, C.D., Thomas, E.D., Kopecky, K.J., Appelbaum, F.R., Talman, M., Storb, R., Sanders, J., Sullivan, K., Banaji, M., Beatty, P.S., Bensinger, W., Cheever, M., Deeg, J., Doney, K., Fefer, A., Greenberg, P., Hansen, J.A., Hackman, R., Hill, R., Martin, P., Meyers, J., McGuffin, R., Neiman, P., Sale, G., Shulman, H., Singer, J., Stewart, P., Weiden, P. & Witherspoon, R. (1987) The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation. Bone Marrow Transplantation, 2, 243–258. PubMedWeb of Science®Google Scholar Clift, R.A., Buckner, C.D., Appelbaum, F.R., Schoch, G., Petersen, F.B., Bensinger, W.I., Sanders, J., Sullivan, K.M., Storb, R., Singer, J., Hansen, J.A. & Thomas, C.D. (1992) Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia. Journal of Clinical Oncology, 10, 1723–1729. 10.1200/JCO.1992.10.11.1723 CASPubMedWeb of Science®Google Scholar Creutzig, U., Ritter, J. & Schellong, G. (1990) Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. AML-BFM Study Group. Blood, 75, 1932–1940. PubMedWeb of Science®Google Scholar Creutzig, U., Ritter, J., Vormoor, J., Ludwig, W.D., Niemeyer, C., Reinisch, I., Stollmann-Gibbels, B., Zimmermann, M. & Harbott, J. (1996) Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group. Leukemia, 10, 1677–1686. CASPubMedWeb of Science®Google Scholar Dahl, G.V., Kalwinsky, D.K., Mirro, Jr, J., Look, A.T., Pui, C.H., Murphy, S.B., Mason, C., Ruggiero, M., Schell, M., Johnson, F.L. & Thomas, E.D. (1990) Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission. Journal of Clinical Oncology, 8, 295–303. 10.1200/JCO.1990.8.2.295 CASPubMedWeb of Science®Google Scholar Fenaux, P., Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., Fey, M., Rayon, C., Huguet, F., Sotto, J.J., Gardin, C., Makhoul, P.C., Travade, P., Solary, E., Fegueux, N., Bordessoule, D., Miguel, J.S., Link, H., Desablens, B., Stamatoullas, A., Deconinck, E., Maloisel, F., Castaigne, S., Preudhomme, C. & Degos, L. (1999) A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood, 94, 1192–1200. 10.1182/blood.V94.4.1192 CASPubMedWeb of Science®Google Scholar Ferrant, A., Labopin, M. & Gorin, N.C. (1997a) Karyotype in acute myeloblastic leukemia. Prognostic significance for bone marrow transplantation in first remission. A European Group for Blood and Marrow Transplantation Study. Blood, 90, 2931. CASPubMedWeb of Science®Google Scholar Ferrant, A., Labopin, M., Frassoni, F., Prentice, H.G., Cahn, J.Y., Blaise, D., Reiffers, J., Visani, G., Sanz, M.A., Boogaerts, M.A., Lowenberg, B. & Gorin, N.C. (1997b) Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Blood, 90, 2931–2938. CASPubMedWeb of Science®Google Scholar Gale, R.P., Horowitz, M.M., Weiner, R.S., Ash, R.C., Atkinson, K., Babu, R., Dicke, K.A., Klein, J.P., Lowenberg, B., Reiffers, J., Rimm, A.A., Rowlings, P.A., Sandberg, A.A., Sobocinski, K.A., Veum-Stone, J. & Bortin, M.M. (1995) Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission. Bone Marrow Transplantation, 16, 203–208. CASPubMedWeb of Science®Google Scholar Hongeng, S., Krance, R.A., Bowman, L.C., Srivastava, D.K., Cunningham, J.M., Horwitz, E.M., Brenner, M.K. & Heslop, H.E. (1997) Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia. Lancet, 350, 767–771. 10.1016/S0140-6736(97)03098-5 PubMedWeb of Science®Google Scholar Lange, B.J., Kobrinsky, N., Barnard, D.R., Arthur, D.C., Buckley, J.D., Howells, W.B., Gold, S., Sanders, J., Neudorf, S., Smith, F.O. & Woods, W.G. (1998) Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome. Children's Cancer Group Studies 2861 and 2891. Blood, 91, 608–615. CASPubMedWeb of Science®Google Scholar Lo Coco, F., Diverio, D., Avvisati, G., Petti, M.C., Meloni, G., Pogliani, E.M., Biondi, A., Rossi, G., Carlo-Stella, C., Selleri, C., Martino, B., Specchia, G. & Mandelli, F. (1999) Therapy of molecular relapse in acute promyelocytic leukemia. Blood, 94, 2225–2229. 10.1182/blood.V94.7.2225.419k03_2225_2229 CASPubMedWeb of Science®Google Scholar Mandelli, F., Labopin, M., Granena, A., Iriondo, A., Prentice, G., Bacigalupo, A., Sierra, J., Meloni, G., Frassoni, F., Goldman, J., Gratwohl, A. & Gorin, N.C. (1994) European survey of bone marrow transplantation in acute promyelocytic leukemia (M3). Working Party on Acute Leukemia of the European Cooperative Group for Bone Marrow Transplantation (EMBT). Bone Marrow Transplantation, 14, 293–298. CASPubMedWeb of Science®Google Scholar Meloni, G., Diverio, D., Vignetti, M., Avvisati, G., Capria, S., Petti, M.C., Mandelli, F. & Lo Coco, F. (1997) Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gene. Blood, 90, 1321–1325. 10.1182/blood.V90.3.1321 CASPubMedWeb of Science®Google Scholar Nesbit, Jr, M.E., Buckley, J.D., Feig, S.A., Anderson, J.R., Lampkin, B., Bernstein, I.D., Kim, T.H., Piomelli, S., Kersey, J.H., Coccia, P.F., O'Reilly, R.C., August, C., Thomas, E.D. & Hammond, G.D. (1994) Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. Journal of Clinical Oncology, 12, 127–135. CASPubMedWeb of Science®Google Scholar Parsons, S.K., Gelber, S., Cole, B.F., Ravindranath, Y., Ogden, A., Yeager, A.M., Chang, M., Shuster, J., Weinstein, H.J. & Gelber, R.D. (1999) Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: a Q-TWiST analysis of the Pediatric Oncology Group Study 8821. Journal of Clinical Oncology, 17, 2144–2152. 10.1200/JCO.1999.17.7.2144 CASPubMedWeb of Science®Google Scholar Radich, J.P., Sanders, J.E., Buckner, C.D., Martin, P.J., Petersen, F.B., Bensinger, W., McDonald, G.B., Mori, M., Schoch, G. & Hansen, J.A. (1993) Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens. Journal of Clinical Oncology, 11, 304–313. 10.1200/JCO.1993.11.2.304 PubMedWeb of Science®Google Scholar Raimondi, S.C., Chang, M.N., Ravindranath, Y., Behm, F.G., Gresik, M.V., Steuber, C.P., Weinstein, H.J. & Carroll, A.J. (1999) Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a Cooperative Pediatric Oncology Group study-POG 8821. Blood, 94, 3707–3716. CASPubMedWeb of Science®Google Scholar Ravindranath, Y., Abella, E., Krischer, J.P., Wiley, J., Inoue, S., Harris, M., Chauvenet, A., Alvarado, C.S., Dubowy, R. & Ritchey, A.K. (1992) Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Blood, 80, 2210–2214. 10.1182/blood.V80.9.2210.2210 CASPubMedWeb of Science®Google Scholar Ravindranath, Y., Yeager, A.M., Chang, M.N., Steuber, C.P., Krischer, J., Graham-Pole, J., Carroll, A., Inoue, S., Camitta, B. & Weinstein, H.J. (1996) Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group. New England Journal of Medicine, 334, 1428–1434.DOI: 10.1056/NEJM199605303342203 10.1056/NEJM199605303342203 PubMedWeb of Science®Google Scholar Sanders, J.E., Thomas, E.D., Buckner, C.D., Flournoy, N., Stewart, P.S., Clift, R.A., Lum, L., Bensinger, W.I., Storb, R. & Appelbaum, F.R. (1985) Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: an update. Blood, 66, 460–462. PubMedWeb of Science®Google Scholar Santos, G.W., Tutschka, P.J., Brookmeyer, R., Saral, R., Beschorner, W.E., Bias, W.B., Braine, H.G., Burns, W.H., Elfenbein, G.J., Kaizer, H., Mellits, D., Sensenbrenner, L.L., Stuart, R.K. & Yeager, A.M. (1983) Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. New England Journal of Medicine, 309, 1347–1353. 10.1056/NEJM198312013092202 PubMedWeb of Science®Google Scholar Sanz, M.A., Lo Coco, F., Martin, G., Avvisati, G., Rayon, C., Barbui, T., Diaz-Mediavilla, J., Fioritoni, G., Gonzalez, J.D., Liso, V., Esteve, J., Ferrara, F., Bolufer, P., Bernasconi, C., Gonzalez, M., Rodeghiero, F., Colomer, D., Petti, M.C., Ribera, J.M. & Mandelli, F. (2000) Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood, 96, 1247–1253. CASPubMedWeb of Science®Google Scholar Schiffman, K., Clift, R., Appelbaum, F.R., Sanders, J., Bensinger, W., Petersen, F.B., Rowley, S., Hill, R., Martin, P., Storb, R., Weiden, P., Thomas, E.D., Hansen, J.A. & Buckner, C.D. (1993) Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemia. Bone Marrow Transplantation, 11, 227–232. CASPubMedWeb of Science®Google Scholar Schouten, H.C., Van Putten, W.L., Hagemeijer, A., Blijham, G.H., Sonneveld, P., Willemze, R., Slater, R., Van De Lely, J., Verdonck, L.F. & Lowenberg, B. (1991) The prognostic significance of chromosomal findings in patients with acute myeloid leukemia in a study comparing the efficacy of autologous and allogeneic bone marrow transplantation. Bone Marrow Transplantation, 8, 377–381. PubMedWeb of Science®Google Scholar Scott, A., Pearce, D. & Goldblatt, P. (2001) The sizes and characteristics of the minority ethnic populations of Great Britain – latest estimates. Population Trends, 6–15. Google Scholar Shaw, P.J., Bergin, M.E., Burgess, M.A., Dalla Pozza, L., Kellie, S.J., Rowell, G., Stevens, M.M., Webster, B.H. & Bradstock, K.F. (1994) Childhood acute myeloid leukemia: outcome in a single center using chemotherapy and consolidation with busulfan/cyclophosphamide for bone marrow transplantation. Journal of Clinical Oncology, 12, 2138–2145. 10.1200/JCO.1994.12.10.2138 CASPubMedWeb of Science®Google Scholar Slovak, M.L., Kopecky, K.J., Wolman, S.R., Henslee-Downey, J.P., Appelbaum, F.R., Forman, S.J. & Blume, K.G. (1995) Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: aSouthwest Oncology Group study (SWOG-8612). Leukemia Research, 19, 381–388.DOI: 10.1016/0145-2126(94)00162-4 10.1016/0145-2126(94)00162-4 CASPubMedWeb of Science®Google Scholar Smith, F., Howells, W., Buckley, J., Arthur, D., Barnard, D., Lange, B., Kobrinsky, N., Sanders, J., Neudorf, S., Gold, S., DeSwarte, J., Dusenberry, K., Woods, W. & Group, C.S.C. (1997) Prognostic factors in children with acute myeloid leukemia: results of Children's Cancer Group protocol 2891. Blood, 90, 561a. Google Scholar Stevens, R.F., Hann, I.M., Wheatley, K. & Gray, R.G. (1998) Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party. British Journal of Haematology, 101, 130–140.DOI: 10.1046/j.1365-2141.1998.00677.x 10.1046/j.1365-2141.1998.00677.x CASPubMedWeb of Science®Google Scholar Szydlo, R., Goldman, J.M., Klein, J.P., Gale, R.P., Ash, R.C., Bach, F.H., Bradley, B.A., Casper, J.T., Flomenberg, N., Gajewski, J.L., Gluckman, E., Henslee-Downey, P.J., Hows, J.M., Jacobsen, N., Kolb, H.J., Lowenberg, B., Masaoka, T., Rowlings, P.A., Sondel, P.M., Van Bekkum, D.W., Van Rood, J.J., Vowels, M.R., Zhang, M.J. & Horowitz, M.M. (1997) Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. Journal of Clinical Oncology, 15, 1767–1777. 10.1200/JCO.1997.15.5.1767 PubMedWeb of Science®Google Scholar Thomas, E.D., Buckner, C.D., Clift, R.A., Fefer, A., Johnson, F.L., Neiman, P.E., Sale, G.E., Sanders, J.E., Singer, J.W., Shulman, H., Storb, R. & Weiden, P.L. (1979) Marrow transplantation for acute nonlymphoblastic leukemia in first remission. New England Journal of Medicine, 301, 597–599. 10.1056/NEJM197909133011109 PubMedWeb of Science®Google Scholar Vowels, M., Stevens, M., Tiedemann, K. & Brown, R. (1992) Autologous and allogeneic bone marrow transplantation for childhood acute nonlymphoblastic leukemia. Transplantation Proceedings, 24, 184–185. CASPubMedWeb of Science®Google Scholar Watson, M., Wheatley, K., Harrison, G.A., Zittoun, R., Gray, R.G., Goldstone, A.H. & Burnett, A.K. (1999) Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial. Cancer, 86, 1231–1239.DOI: 10.1002/(SICI)1097-0142(19991001)86:7 3.0.CO;2-Y 10.1002/(SICI)1097-0142(19991001)86:7 3.0.CO;2-Y CASPubMedWeb of Science®Google Scholar Webb, D.K., Harrison, G., Stevens, R.F., Gibson, B.G., Hann, I.M. & Wheatley, K. (2001) Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia. Blood, 98, 1714–1720. 10.1182/blood.V98.6.1714 CASPubMedWeb of Science®Google Scholar Wells, R.J., Woods, W.G., Buckley, J.D., Odom, L.F., Benjamin, D., Bernstein, I., Betcher, D., Feig, S., Kim, T. & Ruymann, F. (1994) Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: a Childrens Cancer Group study. Journal of Clinical Oncology, 12, 2367–2377. 10.1200/JCO.1994.12.11.2367 PubMedWeb of Science®Google Scholar Woods, W.G., Kobrinsky, N., Buckley, J.D., Lee, J.W., Sanders, J., Neudorf, S., Gold, S., Barnard, D.R., DeSwarte, J., Dusenbery, K., Kalousek, D., Arthur, D.C. & Lange, B.J. (1996) Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group. Blood, 87, 4979–4989. 10.1182/blood.V87.12.4979.bloodjournal87124979 CASPubMedWeb of Science®Google Scholar Woods, W.G., Neudorf, S., Gold, S., Sanders, J., Buckley, J.D., Barnard, D.R., Dusenbery, K., DeSwarte, J., Arthur, D.C., Lange, B.J. & Kobrinsky, N.L. (2001a) A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children's cancer group. Blood, 97, 56–62. 10.1182/blood.V97.1.56 CASPubMedWeb of Science®Google Scholar Woods, W., Lange, B., Smith, F. & Alonzo, T. (2001b) A comparison of allogeneic bone marrow transplantation (BMT), autologous BMT, and chemotherapy in pediatric acute myeloid leukemia [letter]. Blood, 97, 3674–3675. 10.1182/blood.V97.1.56 CASWeb of Science®Google Scholar Citing Literature Volume118, Issue2August 2002Pages 378-384 ReferencesRelatedInformation